Tryptophan degradation in patients with gynecological cancer correlates with immune activation - PubMed (original) (raw)
. 2005 Jun 8;223(2):323-9.
doi: 10.1016/j.canlet.2004.10.033. Epub 2004 Dec 8.
Affiliations
- PMID: 15896467
- DOI: 10.1016/j.canlet.2004.10.033
Tryptophan degradation in patients with gynecological cancer correlates with immune activation
Katharina Schroecksnadel et al. Cancer Lett. 2005.
Abstract
Tryptophan degradation by the enzyme indoleamine-(2,3)-dioxy genase (IDO) and neopterin production are induced within cellular immune activation by stimulation of monocyte-derived macrophages and dendritic cells with cytokine interferon-gamma. Deprivation of tryptophan represents an important antimicrobial and antitumoral immune defence mechanism but it also suppresses T-cell proliferation. Recently tryptophan degradation by tumor cells was proposed as strategy to escape immune response. In this study the relationship between tryptophan degradation and immune activation was examined in 20 patients with gynecological cancer. Concentrations of tryptophan and kynurenine were measured by HPLC in sera of patients, and to estimate IDO activity, the kynurenine to tryptophan ratio was calculated. In parallel, neopterin concentrations were measured by ELISA. Tryptophan concentrations (median, interquartile range: 43.5, 31.2-56.3 microM) were lower in patients with gynecological cancer compared to healthy individuals of similar age (53.5, 47.0-64.2 microM; P<0.05). Kynurenine concentrations (median: 1.91 vs. 1.73 microM in controls) and kyn/trp (median: 41 vs. 35 micromol/mmol in controls) were slightly higher in patients, but not significantly different. Neopterin concentrations were significantly higher in patients (median: 10.8 vs. 7.0 nM in controls; P<0.05) and correlated with the kynurenine per tryptophan ratio (r(s)=0.555; P<0.02). In conclusion, tryptophan degradation is detectable in patients with gynecological cancer. The relationship between kyn/trp and neopterin concentrations indicates that cellular immune activation rather than tumor-mediated IDO-activity is responsible (228 words).
Similar articles
- Increased degradation of tryptophan in blood of patients with rheumatoid arthritis.
Schroecksnadel K, Kaser S, Ledochowski M, Neurauter G, Mur E, Herold M, Fuchs D. Schroecksnadel K, et al. J Rheumatol. 2003 Sep;30(9):1935-9. J Rheumatol. 2003. PMID: 12966593 - Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Suzuki Y, Suda T, Furuhashi K, Suzuki M, Fujie M, Hahimoto D, Nakamura Y, Inui N, Nakamura H, Chida K. Suzuki Y, et al. Lung Cancer. 2010 Mar;67(3):361-5. doi: 10.1016/j.lungcan.2009.05.001. Epub 2009 May 31. Lung Cancer. 2010. PMID: 19487045 - Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers.
Sperner-Unterweger B, Neurauter G, Klieber M, Kurz K, Meraner V, Zeimet A, Fuchs D. Sperner-Unterweger B, et al. Immunobiology. 2011 Mar;216(3):296-301. doi: 10.1016/j.imbio.2010.07.010. Epub 2010 Aug 19. Immunobiology. 2011. PMID: 20822828 - Monitoring tryptophan metabolism in chronic immune activation.
Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D. Schröcksnadel K, et al. Clin Chim Acta. 2006 Feb;364(1-2):82-90. doi: 10.1016/j.cca.2005.06.013. Epub 2005 Sep 1. Clin Chim Acta. 2006. PMID: 16139256 Review. - Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
Zamanakou M, Germenis AE, Karanikas V. Zamanakou M, et al. Immunol Lett. 2007 Aug 15;111(2):69-75. doi: 10.1016/j.imlet.2007.06.001. Epub 2007 Jul 2. Immunol Lett. 2007. PMID: 17644189 Review.
Cited by
- Oncology Therapeutics Targeting the Metabolism of Amino Acids.
Muhammad N, Lee HM, Kim J. Muhammad N, et al. Cells. 2020 Aug 15;9(8):1904. doi: 10.3390/cells9081904. Cells. 2020. PMID: 32824193 Free PMC article. Review. - Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
Kurgan Ş, Önder C, Balcı N, Akdoğan N, Altıngöz SM, Serdar MA, Günhan M. Kurgan Ş, et al. Clin Oral Investig. 2022 Sep;26(9):5721-5732. doi: 10.1007/s00784-022-04528-4. Epub 2022 May 19. Clin Oral Investig. 2022. PMID: 35588020 - Interferon-γ-induced inflammatory markers and the risk of cancer: the Hordaland Health Study.
Zuo H, Tell GS, Vollset SE, Ueland PM, Nygård O, Midttun Ø, Meyer K, Ulvik A, Eussen SJ. Zuo H, et al. Cancer. 2014 Nov 1;120(21):3370-7. doi: 10.1002/cncr.28869. Epub 2014 Jun 19. Cancer. 2014. PMID: 24948355 Free PMC article. - Induction of tryptophan hydroxylase in the liver of s.c. tumor model of prostate cancer.
Hagiwara A, Nakamura Y, Nishimoto R, Ueno S, Miyagi Y. Hagiwara A, et al. Cancer Sci. 2020 Apr;111(4):1218-1227. doi: 10.1111/cas.14333. Epub 2020 Feb 27. Cancer Sci. 2020. PMID: 31997472 Free PMC article. - Utility of kynurenic acid for non-invasive detection of metastatic spread to lymph nodes in non-small cell lung cancer.
Sagan D, Kocki T, Patel S, Kocki J. Sagan D, et al. Int J Med Sci. 2015 Jan 7;12(2):146-53. doi: 10.7150/ijms.7541. eCollection 2015. Int J Med Sci. 2015. PMID: 25589891 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials